Gut Microbiome Atlas: Mapping Bacterial Diversity and Health

One of the most consequential mapping projects in modern biology charted territory nobody can see. Over the past two decades scientists have mapped the microbial landscape of the human digestive tract, and that effort has changed how we understand health, disease and the relationships between our bodies and the microorganisms living within them.

The scale is worth stating precisely, because it is frequently overstated. The most careful estimate, by Sender, Fuchs and Milo, puts the number of bacteria in a reference 70 kilogram adult at about 3.8 x 10^13, against roughly 3.0 x 10^13 human cells, a ratio of about 1.3 to 1 rather than the 10 to 1 figure repeated for decades. The great majority live in the colon, with a combined wet mass of around 0.2 kilograms (PLOS Biology, 2016).

This article covers what modern microbiome research has established about bacterial diversity, how it is measured, why it matters clinically, and how VOC analysis opens a complementary window on microbial community function.

The Human Microbiome Project: Establishing the Baseline

The Human Microbiome Project, launched in 2007 and reported in 2012, established a reference for microbial communities across body sites in healthy volunteers. It characterized 242 healthy adults sampled at up to 18 body sites, generating 16S rRNA gene sequence data describing phylogenetic diversity alongside shotgun metagenomic data describing functional genetic capacity (Nature, 2012; Turnbaugh et al., Nature, 2007).

It was preceded by smaller but foundational work. Eckburg and colleagues sequenced 13,355 prokaryotic ribosomal RNA gene sequences from colonic mucosal sites and stool in healthy adults, and found that the great majority corresponded to uncultivated species and previously undescribed organisms, with Bacteroidetes and Firmicutes dominating (Science, 2005). That result set the agenda for everything that followed: most of what lives in the gut had never been grown in a laboratory.

The gene catalogues quantified the functional side. The MetaHIT consortium described 3.3 million non-redundant microbial genes from 124 European individuals (Qin et al., Nature, 2010), later expanded to 9.9 million genes from 1,267 samples across three continents (Li et al., Nature Biotechnology, 2014). For comparison, the human genome contains roughly 20,000 protein-coding genes.

The foundational insight from this work was that healthy human guts show remarkable species-level diversity while still clustering into recognizable compositional patterns. Two people could differ radically at the species level and both maintain metabolically functional, resilient microbiota. This pointed toward a concept that still shapes gut microbiome research: functional redundancy.

The Major Phyla

Bacterial diversity in the human gut is organized hierarchically, and at the broadest level five phyla dominate in most populations. The relative abundance ranges below are those typically reported across Western adult cohorts in the reference literature, and inter-individual variation around them is large (Human Microbiome Project Consortium, 2012; Lozupone et al., Nature, 2012).

Phylum	Typical relative abundance in Western adults	Key genera	Principal metabolic role	Characteristic volatile output
Firmicutes	Roughly 50 to 60 percent	Faecalibacterium, Roseburia, Eubacterium, Clostridium, Ruminococcus	Fiber fermentation to butyrate via the butyryl-CoA pathway	Butyrate and other short-chain fatty acids
Bacteroidetes	Roughly 20 to 30 percent	Bacteroides, Prevotella, Alistipes	Complex polysaccharide degradation	Acetate and propionate, branched-chain fatty acids under protein load
Actinobacteria	Single-digit percentages in most adults	Bifidobacterium, Collinsella	Oligosaccharide fermentation, dominant in breastfed infants	Acetate and lactate
Proteobacteria	Typically a low single-digit percentage	Escherichia, Klebsiella, Desulfovibrio	Facultative anaerobic metabolism; expansion often marks dysbiosis	Indole, sulfur compounds
Verrucomicrobia	Usually a few percent or less	Akkermansia	Mucin degradation and mucosal barrier interaction	Acetate and propionate from mucin

Firmicutes include the spore-forming Clostridium genus, Faecalibacterium prausnitzii and Roseburia species. They are characteristically gram-positive obligate anaerobes specialized for converting dietary fiber into short-chain fatty acids, particularly butyrate.

Bacteroidetes excel at metabolizing complex polysaccharides from plant cell walls, possessing extensive carbohydrate-degrading enzyme systems that access dietary carbohydrates human enzymes cannot (Ottman et al., Frontiers in Cellular and Infection Microbiology, 2012).

Actinobacteria are early colonizers. Backhed and colleagues followed infants through the first year of life and documented how Bifidobacterium dominates in breastfed infants before cessation of breastfeeding, rather than introduction of solid food, triggers the shift toward an adult-like community (Cell Host & Microbe, 2015).

Proteobacteria comprise only a small percentage of healthy gut microbiota despite dominating other body sites. The gut environment appears to select against them, which is why elevated Proteobacteria is often treated as a dysbiosis marker.

Verrucomicrobia are represented mainly by Akkermansia muciniphila, which degrades the mucin layer lining the intestinal epithelium. Depommier and colleagues ran the first human proof-of-concept supplementation study with pasteurized A. muciniphila in overweight and obese volunteers and reported improvements in insulin sensitivity and some metabolic markers over three months, a small exploratory study rather than a definitive one (Nature Medicine, 2019).

The Firmicutes to Bacteroidetes Ratio: A Cautionary Tale

One of the most widely reported microbiome metrics is the Firmicutes to Bacteroidetes ratio. Ley and colleagues reported in 2006 that obese individuals had relatively fewer Bacteroidetes and more Firmicutes than lean individuals, and that the proportion shifted toward Bacteroidetes as subjects lost weight on either a fat-restricted or carbohydrate-restricted low-calorie diet, correlating with percentage weight loss rather than calorie count (Nature, 2006). The finding was influential and became cemented in popular discourse as a marker of metabolic dysfunction.

Subsequent research has substantially complicated that narrative. Large studies demonstrate enormous natural variation in this ratio among healthy people, and the ratio shows poor predictive power for body mass index or metabolic outcomes when examined in rigorous prospective studies. Both high and low ratios can accompany good health depending on which specific genera and species are involved.

This evolution reflects a broader principle: aggregate metrics at the phylum level obscure functional heterogeneity. Faecalibacterium prausnitzii, a Firmicute, is widely treated as a marker of health because of its butyrate production and anti-inflammatory properties, while certain Clostridium species, also Firmicutes, are associated with pathogenic responses. The genus matters. The species matters. The ratio alone tells an incomplete story.

Vandeputte and colleagues added a further reason for caution: total microbial load varies roughly tenfold between individuals, so any ratio computed from relative abundance can move without any absolute population actually changing (Nature, 2017).

Key Genera and Species

Bacteroides are the premier polysaccharide degraders, carrying the enzymatic machinery to break down complex plant cell wall components, which gives them considerable metabolic flexibility as diet changes.

Faecalibacterium prausnitzii is perhaps the most discussed organism in microbiome research. Sokol and colleagues showed it is depleted in Crohn's disease patients, and that both the organism and its cell-free culture supernatant reduced inflammation in experimental colitis in mice and corrected the associated dysbiosis (PNAS, 2008). That is one of the clearest examples in the field of an abundance association followed by a functional test.

Akkermansia muciniphila is a mucus-layer specialist whose abundance correlates with improved metabolic parameters and reduced inflammation in multiple studies, with the first small human supplementation trial reporting metabolic improvements over three months (Depommier et al., 2019).

Prevotella illustrates geographic variation. It dominates in populations consuming high-carbohydrate, plant-based diets while remaining minor in typical Western microbiota. Vangay and colleagues tracked what happens when that environment changes, following immigrants from Southeast Asia to the United States and documenting loss of native diversity, loss of Prevotella dominance, and functional shifts that began within months of relocation and compounded across generations (Cell, 2018).

Bifidobacterium species dominate infant microbiota, especially in breastfed infants, because human milk oligosaccharides are complex carbohydrates human enzymes cannot digest but bifidobacteria ferment preferentially. They persist at lower abundance in adults, and clinical evidence for supplementation efficacy remains inconsistent across studies.

Roseburia and Ruminococcus species are secondary butyrate producers fermenting dietary fibers and resistant starches, and their abundance tends to correlate with higher fiber intake.

Lactobacillus species form a surprisingly small proportion of healthy adult gut microbiota despite extensive probiotic marketing. Much of the Lactobacillus detected in the gut derives from oral carriage or temporary transit following ingestion.

Enterotypes: Structure Within Variation

In 2011, Arumugam and colleagues analyzed microbiota composition across populations from diverse geographic regions and identified three primary enterotypes, distinguished by dominant genera: one enriched in Bacteroides, one dominated by Prevotella, and one characterized by Ruminococcus. The suggestion was that human microbiota might occupy distinct stable states, and that these clusters appeared independent of nationality, age, sex and body mass index (Nature, 2011).

Subsequent research has added important nuance. Reappraisals using larger datasets and refined statistical methods suggest enterotypes represent points on a continuum rather than discrete categories. The boundaries are fuzzy, individuals move between classifications following major dietary shifts or antibiotic exposure, and the clinical relevance for predicting outcomes or treatment response remains uncertain. Vandeputte and colleagues showed that stool consistency alone is strongly associated with enterotype assignment, which means some of what looks like a stable community type may partly reflect transit time.

Contemporary work therefore treats enterotypes as useful conceptual anchors representing major compositional strategies rather than as fixed states.

Measuring Diversity

Metric	Type	What it captures	Best used for	Known limitation
Observed richness	Alpha	Number of distinct taxa detected	Simple comparison within one protocol	Highly sensitive to sequencing depth and rarefaction choices
Chao1	Alpha	Estimated total richness including unobserved rare taxa	Correcting for undersampling	Estimator variance is high when rare taxa dominate
Shannon index	Alpha	Richness and evenness combined	General-purpose within-sample diversity	Two very different communities can share a value
Simpson index	Alpha	Dominance, weighting abundant taxa more heavily	Detecting overgrowth of a single taxon	Insensitive to loss of rare organisms
Bray-Curtis dissimilarity	Beta	Compositional difference based on abundance	Comparing samples or timepoints	Ignores how related the taxa are to each other
UniFrac (weighted and unweighted)	Beta	Compositional difference weighted by phylogenetic distance	Comparing communities across populations	Depends on the quality of the reference phylogeny

Alpha diversity measures diversity within a single sample, encompassing both the number of distinct taxa and their relative abundances. Higher alpha diversity generally correlates with better health outcomes, though the relationship is not universal. Some specialized, low-diversity microbiota support good health when dominated by beneficial organisms.

Beta diversity measures compositional differences between samples or individuals. UniFrac distances incorporate phylogenetic relationships, recognizing that losing a distant relative creates more compositional difference than losing one of two closely related species.

Beta diversity patterns across populations reveal how geography, diet and lifestyle structure microbiome variation, a point Ley and colleagues extended across mammalian evolution by showing that gut microbiota composition tracks host phylogeny and diet across species (Science, 2008).

The Diversity Hypothesis

The observation that higher alpha diversity correlates with healthier metabolic profiles has become central to how the field thinks about gut health optimization. The hypothesis is that more diverse communities are more resilient to perturbation, more metabolically flexible, and better able to resist dysbiotic shifts. Lozupone and colleagues set out the ecological framework for this in terms of diversity, stability and resilience (Nature, 2012).

The mechanistic basis is functional complementarity. Diverse communities contain organisms with overlapping but distinct enzymatic capabilities, so the loss of one butyrate producer can be partly compensated by others.

The hypothesis requires caveats. Some high-diversity microbiota accompany poor outcomes if that diversity includes organisms producing harmful metabolites. The relationship between diversity and health is mediated by composition and function, not by richness metrics alone. For the broader research context, see our overview of gut microbiome science and VOC analysis.

Geographic and Genetic Variation

Studies including non-Western populations revealed striking geographic variation. Populations from industrialized nations show lower alpha diversity and distinct clustering compared with populations consuming traditional high-fiber plant-based diets, and those populations often show substantially higher Prevotella abundance.

The relative contribution of genetics has been directly measured, and it is smaller than the folk version suggests. Rothschild and colleagues analyzed more than 1,000 individuals and concluded that environment dominates over host genetics in shaping the gut microbiota, with genetic ancestry explaining only a small fraction of compositional variance and unrelated people sharing a household showing significant microbiome similarity (Nature, 2018). Goodrich and colleagues had earlier used the TwinsUK twin design to show that some specific taxa are meaningfully heritable while most are not, with Christensenellaceae the most heritable taxon identified and associated with lean body mass (Cell, 2014).

Both findings can be true at once: a small number of taxa are under real host genetic influence, while overall composition is dominated by environment and diet.

Life Course Dynamics

The microbiota changes substantially across the lifespan. Backhed and colleagues followed a birth cohort through the first year of life and showed that infant microbiota establishes through environmental exposure at birth, with delivery mode influencing initial colonization, that Bifidobacterium dominates in breastfed infants, and that cessation of breastfeeding rather than introduction of solid food drives the transition toward an adult-like community (Cell Host & Microbe, 2015).

Adult microbiota then remains relatively stable across decades in people maintaining consistent diet and lifestyle. Ageing is associated with compositional change and, in many cohorts, decreased alpha diversity. The ELDERMET study of 178 elderly subjects found that microbiota composition correlated with diet, with residence setting, and with measures of frailty and inflammation, with community-dwelling participants on more varied diets showing more diverse microbiota than long-stay residents (Claesson et al., Nature, 2012). That is an important detail: the driver in that cohort looked more like diet and setting than age itself.

The Rare Biosphere

While dominant taxa receive most attention, the rare biosphere of organisms present at very low relative abundance exerts influence disproportionate to its size. These organisms maintain enzymatic capabilities for metabolizing unusual substrates and producing specialized metabolites that dominant species cannot.

The rare biosphere provides a kind of metabolic insurance. If dominant butyrate producers are depleted by illness or antibiotics, rare butyrate producers may expand and restore function. Sequencing-based studies likely underestimate rare biosphere diversity for technical reasons.

Functional Redundancy and the Resilience Paradox

One of the field's most important insights is that different taxa can perform similar metabolic functions. The gut's ability to produce butyrate, metabolize complex carbohydrates or synthesize certain vitamins does not depend on any single organism but on a consortium of functionally overlapping species.

That redundancy confers resilience. But redundancy is not universal across pathways. Some species possess unique capabilities found nowhere else in the community, and losing such a keystone organism can trigger substantial reorganization or a genuine functional deficit.

This distinction explains why microbiota survive some perturbations and collapse under others. Eliminating one of five butyrate producers barely affects total production. Eliminating the sole organism capable of a specific conversion creates a bottleneck. Ley, Peterson and Gordon set out the ecological and evolutionary logic behind this in what remains the standard framing (Cell, 2006).

VOC Profiles as Windows into Community Structure

Culture-independent DNA sequencing dominates microbiome characterization in research, but it requires substantial infrastructure, expertise and cost. Volatile organic compound analysis offers a complementary approach that reveals microbial metabolism without directly sequencing composition.

Different bacterial groups produce characteristic volatile patterns reflecting metabolic specialization. Butyrate-producing Firmicutes generate short-chain fatty acid profiles distinct from those of polysaccharide-fermenting Bacteroides. Proteolytic organisms generate ammonia, indoles and other nitrogen-containing compounds. Parada Venegas and colleagues set out how short-chain fatty acid production connects to epithelial and immune regulation, which is the reason these particular volatiles carry clinical meaning (Frontiers in Immunology, 2019).

Transit time is a major modifier. Roager and colleagues showed that colonic transit time governs whether metabolism runs saccharolytic or proteolytic, so a volatile profile reports on the interaction between community composition and gut physiology rather than composition alone (Nature Microbiology, 2016).

SNIFR's platform is designed around this principle: capturing the metabolic signature of the underlying bacterial community rather than producing genus-level taxonomic identification. The technology is currently in development and has not been clinically validated.

Hypothetical scenario. As an illustrative scenario, imagine two people with identical Shannon diversity indices. One carries an established population of Faecalibacterium prausnitzii and Roseburia; the other does not, with the same index made up of a broader spread of proteolytic organisms. Based on the mechanisms described above, their volatile profiles would be expected to differ substantially, with the first weighted toward butyrate and the second toward indoles, phenolics and branched-chain fatty acids. A diversity number alone would not separate them. This is a constructed illustration of published mechanism, not a real pair of people and not a SNIFR result.

Keystone Species and Critical Transitions

Ecologists recognize that certain species exert influence on ecosystem structure disproportionate to their biomass, and that their loss can trigger cascading change.

Akkermansia muciniphila is a likely keystone species in the human gut. Despite usually sitting at a few percent relative abundance or less, its presence correlates strongly with metabolic health and immune homeostasis, and the first human supplementation study reported metabolic improvements (Depommier et al., 2019). Faecalibacterium prausnitzii appears to function similarly in inflammatory contexts, with both the organism and its supernatant showing anti-inflammatory effects in animal models (Sokol et al., 2008).

Identifying keystone organisms changes how monitoring data should be read. A microbiota with high alpha diversity but absent keystone species might function poorly, while a lower-diversity community containing key organisms might support good health.

The Dark Matter Problem

Despite decades of research, a substantial fraction of bacterial cells in the human gut remain either unculturable or uncharacterized. Eckburg and colleagues found in 2005 that the great majority of sequences recovered from the human colon corresponded to uncultivated species, and while culturing techniques and metagenome-assembled genomes have narrowed that gap considerably, it has not closed.

This represents a real gap. We cannot determine enzymatic capabilities, metabolic outputs or ecological roles for organisms we cannot culture or characterize genomically. Single-cell genomics, metagenome-assembled genomes and long-read sequencing are beginning to address this.

The dark matter problem also highlights a limitation of taxonomy-based prediction. Metabolic capacity generally cannot be inferred from taxonomy alone, since two organisms within the same genus may possess radically different capabilities.

Resilience, Stability and Recovery

Microbiota resilience, the capacity to return toward baseline after perturbation, depends substantially on diversity and keystone species presence. More diverse communities typically recover faster from antibiotics, dietary shocks or illness, while lower-diversity communities can experience persistent dysbiosis lasting weeks or longer.

Stability reflects a community's position relative to alternative stable states. A microbiota at risk of transition toward a dysbiotic state sits near a threshold where modest perturbations can trigger disproportionate shifts, a pattern observed in individuals experiencing recurrent Clostridioides difficile infection.

Restoring resilience requires both promoting diversity and supporting keystone species re-establishment. Standard probiotic approaches introducing single species rarely restore full function if the underlying ecological conditions remain unchanged.

Beyond the Gut: Distal Associations

Mapping the gut community has also produced associations well outside digestion. Goedert and colleagues conducted a population-based case-control study and found that postmenopausal women with breast cancer had altered fecal microbiota composition and lower alpha diversity than matched controls (Journal of the National Cancer Institute, 2015). Marchesi and colleagues survey the broader clinical landscape of such associations (Gut, 2016), and Valdes and colleagues provide the general-readership synthesis of what the evidence supports on nutrition and health (BMJ, 2018). These are associations in observational data, and they should be read that way.

Practical Implications

Several principles follow from contemporary gut microbiome research for anyone interpreting their own monitoring data:

• Diversity metrics alone do not predict outcomes. Assess composition and function alongside diversity rather than treating richness as a score to maximize.
• Resilience requires both diversity and keystone presence. Watch whether critical organisms including butyrate producers remain established.
• Dietary fiber is the primary lever. A wide variety of plant fibers, comfortably meeting or exceeding the United States Institute of Medicine Adequate Intake of 25 grams per day for adult women and 38 grams per day for adult men, selects for fiber-fermenting organisms and supports short-chain fatty acid production. Increases are usually better tolerated when made gradually with adequate fluid intake, since rapid increases commonly cause bloating and flatulence.
• There is no single ideal composition. Geographic, genetic and individual variation means the useful comparison is against your own baseline rather than a population average.
• Functional signatures often carry more information than composition. A community producing abundant butyrate is a favorable signal regardless of exactly which taxa are generating it.
• Relative abundance is not absolute abundance. Total microbial load varies roughly tenfold between people, so percentages can move without any population actually changing.

Toward Precision Microbiome Medicine

Moving from population-level understanding toward genuinely individualized approaches requires several further advances. Research must continue characterizing the uncultured fraction of the microbiome. Clinical validation studies must work toward establishing causal relationships rather than accumulating further correlations. Scalable monitoring technologies must develop to the point where longitudinal assessment is affordable. And microbiota-targeted interventions require rigorous testing and standardization.

The field is at a point where foundational research has established the scientific framework and technological innovation is expanding monitoring capability, but clinical validation is still catching up. Treating microbiota profiling as a routine health measure remains a plausible future rather than a present reality.

The Microbiota as a Dynamic Ecosystem

Contemporary gut microbiome research has moved beyond cataloguing which organisms live in our guts toward understanding how community structure, diversity and function relate to health. There is no single ideal microbiota. Health appears to depend on maintaining sufficient diversity, keeping keystone organisms established, and generating metabolic outputs that support host physiology.

Your microbiota is not a static feature of your biology but a dynamic ecosystem responding continuously to diet, environment, stress and medication. The atlas is still being written.

Frequently Asked Questions

What is the gut microbiome atlas?

It refers to the collective mapping effort, beginning with the Human Microbiome Project, that catalogued the microbial communities living in and on the human body. That project characterized 242 healthy adults across up to 18 body sites, and parallel gene catalogues grew from 3.3 million microbial genes in 2010 to 9.9 million in 2014. It gave the field its baseline for healthy variation.

How many bacteria are in the human gut?

The best current estimate puts bacteria in a reference 70 kilogram adult at about 3.8 x 10 to the 13th, against roughly 3.0 x 10 to the 13th human cells, a ratio near 1.3 to 1 rather than the older 10 to 1 claim. Almost all live in the colon, weighing around 0.2 kilograms in total. The 30 trillion figure sometimes quoted is the human cell count.

Which bacteria dominate a healthy gut microbiome?

Most healthy Western gut microbiota are dominated by Firmicutes at roughly 50 to 60 percent and Bacteroidetes at roughly 20 to 30 percent, with smaller contributions from Actinobacteria, Proteobacteria and Verrucomicrobia. Within those, Faecalibacterium prausnitzii, Bacteroides species and Akkermansia muciniphila are frequently discussed as functionally important. Inter-individual variation is large.

Is the Firmicutes to Bacteroidetes ratio a useful health marker?

Not as useful as its popularity suggests. Ley and colleagues reported in 2006 that the ratio shifted with weight loss on calorie-restricted diets, but larger studies show enormous natural variation among healthy people and poor predictive power for metabolic outcomes. Total microbial load also varies roughly tenfold between people, so a ratio can move without any population changing.

What is microbiome diversity and why does it matter?

Alpha diversity measures variety within one sample, combining how many taxa are present with how evenly they are distributed, using metrics such as Shannon, Simpson and Chao1. Higher alpha diversity is generally associated with better health outcomes, likely because functional redundancy makes a community more resilient. The association is not universal, since diversity that includes harmful organisms is not protective.

How much of my microbiome is determined by genetics?

Less than most people assume. Rothschild and colleagues analyzed more than 1,000 individuals and found environment dominates over host genetics, with unrelated people sharing a household showing significant microbiome similarity. Twin studies have identified a small number of genuinely heritable taxa, with Christensenellaceae the most heritable, but overall composition is dominated by diet and environment.

What are keystone species in the gut?

Keystone species exert influence on ecosystem function out of proportion to their abundance. Akkermansia muciniphila and Faecalibacterium prausnitzii are frequently discussed as candidates, since their presence correlates with metabolic and immune measures despite modest relative abundance, and both have supporting experimental work. Losing a keystone organism can trigger changes across the community.

How can VOC analysis reveal bacterial community structure?

Different bacterial groups produce characteristic volatile patterns reflecting their metabolic specialization, so the overall volatile profile carries information about which metabolic strategies dominate. Colonic transit time also modifies the profile, shifting metabolism between saccharolytic and proteolytic. This describes the functional output of the community rather than identifying individual species.

References

• The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207-214. doi:10.1038/nature11234
• Turnbaugh PJ, Ley RE, Hamady M, et al. The Human Microbiome Project. Nature. 2007;449(7164):804-810. doi:10.1038/nature06244
• Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635-1638. doi:10.1126/science.1110591
• Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLOS Biology. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65. doi:10.1038/nature08821
• Li J, Jia H, Cai X, et al. An integrated catalog of reference genes in the human gut microbiome. Nature Biotechnology. 2014;32(8):834-841. doi:10.1038/nbt.2942
• Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174-180. doi:10.1038/nature09944
• Ley RE, Turnbaugh PJ, Klein S, et al. Human gut microbes associated with obesity. Nature. 2006;444(7122):1022-1023. doi:10.1038/4441022a
• Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences. 2008;105(43):16731-16736. doi:10.1073/pnas.0804812105
• Ottman N, Smidt H, de Vos WM, et al. The function of our microbiota: who is out there and what do they do? Frontiers in Cellular and Infection Microbiology. 2012;2:104. doi:10.3389/fcimb.2012.00104
• Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. 2019;25(7):1096-1103. doi:10.1038/s41591-019-0495-2
• Backhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host & Microbe. 2015;17(5):690-703. doi:10.1016/j.chom.2015.04.004
• Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488(7410):178-184. doi:10.1038/nature11319
• Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210-215. doi:10.1038/nature25973
• Goodrich JK, Waters JL, Poole AC, et al. Human Genetics Shape the Gut Microbiome. Cell. 2014;159(4):789-799. doi:10.1016/j.cell.2014.09.053
• Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220-230. doi:10.1038/nature11550
• Ley RE, Hamady M, Lozupone C, et al. Evolution of Mammals and Their Gut Microbes. Science. 2008;320(5883):1647-1651. doi:10.1126/science.1155725
• Ley RE, Peterson DA, Gordon JI. Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine. Cell. 2006;124(4):837-848. doi:10.1016/j.cell.2006.02.017
• Vangay P, Johnson AJ, Ward TL, et al. US Immigration Westernizes the Human Gut Microbiome. Cell. 2018;175(4):962-972.e10. doi:10.1016/j.cell.2018.10.029
• Vandeputte D, Kathagen G, D'hoe K, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551(7681):507-511. doi:10.1038/nature24460
• Parada Venegas D, De la Fuente MK, Landskron G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology. 2019;10:277. doi:10.3389/fimmu.2019.00277
• Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nature Reviews Gastroenterology & Hepatology. 2019;16(1):35-56. doi:10.1038/s41575-018-0061-2
• Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330-339. doi:10.1136/gutjnl-2015-309990
• Valdes AM, Walter J, Segal E, et al. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. doi:10.1136/bmj.k2179
• Roager HM, Hansen LBS, Bahl MI, et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nature Microbiology. 2016;1(9):16093. doi:10.1038/nmicrobiol.2016.93
• Goedert JJ, Jones G, Hua X, et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. Journal of the National Cancer Institute. 2015;107(8):djv147. doi:10.1093/jnci/djv147

SNIFR is designed to provide insights about gut health patterns, not to diagnose or treat medical conditions. Individual results may vary as gut health is influenced by numerous factors including diet, stress, sleep, and genetics. SNIFR is currently in development, and features described may evolve before commercial release.